Publications
Information about journal articles, updated at 14-05-2024, from platform CIÊNCIAVITAE.
Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease/spinocerebellar ataxia type 3
Rufino-Ramos, David; Albuquerque, Patrícia R.; Leandro, Kevin; Carmona, Vitor; Martins, Inês M.; Fernandes, Rita; Henriques, Carina; et al, Molecular Therapy. 1275 - 1292. 5. 31. 2023. http://dx.doi.org/10.1016/j.ymthe.2023.04.001 . 10.1016/j.ymthe.2023.04.001 . Molecular Therapy
miRNA-Mediated Knockdown of ATXN3 Alleviates Molecular Disease Hallmarks in a Mouse Model for Spinocerebellar Ataxia Type 3
Nobre, Rui Jorge; Diana D. Lobo; Carina Henriques; Sonia P. Duarte; Sara M. Lopes; Ana C. Silva; Miguel M. Lopes; et al, Nucleic Acid Therapeutics. 2022. https://doi.org/10.1089/nat.2021.0020 . 10.1089/nat.2021.0020 . Nucleic Acid Therapeutics
miRNA mediated knockdown of ATXN3 alleviates molecular disease hallmarks in a mouse model for Spinocerebellar ataxia type 3
Nobre, Rui Jorge; Lobo, Diana Duarte; Henriques, Carina; Pereira de Almeida, Luis Fernando Morgado, Nucleic Acid Therapeutics. 2021. accepted Nucleic Acid Therapeutics
ULK overexpression mitigates motor deficits and neuropathology in mouse models of Machado-Joseph disease
Vasconcelos-Ferreira, Ana; Martins, Inês Morgado; Lobo, Diana; Pereira, Dina; Lopes, Miguel M.; Faro, Rosário; Lopes, Sara M.; et al, Molecular Therapy. 2021. http://dx.doi.org/10.1016/j.ymthe.2021.07.012 . 10.1016/j.ymthe.2021.07.012 . published Molecular Therapy
The blood-brain barrier is disrupted in Machado-Joseph disease/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples
Duarte Lobo, Diana; Nobre, Rui Jorge; Oliveira Miranda, Catarina; Pereira, Dina; Castelhano, João; Sereno, José; Koeppen, Arnulf; Castelo-Branco, Miguel; Pereira de Almeida, Luís, Acta Neuropathologica Communications. 1. 8. 2020. http://dx.doi.org/10.1186/s40478-020-00955-0 . 10.1186/s40478-020-00955-0 . published Acta Neuropathologica Communications
5 6 out of 6 Publications
All projects
Information of exclusive responsibility of the researcher 14-05-2024 , from platform CIÊNCIAVITAE.
2023/03/01 - 2024/08/31
Direct Conversion of Astrocytes into Cerebellar Neurons as an Innovative Treatment for Spinocerebellar Ataxia Type-3
2022.06127.PTDC
Universidade de Coimbra
Funders: Fundação para a Ciência e a Tecnologia
2023/09/01 - 2026/08/31
NEURODIET - Molecular Mechanisms of Dietary Intervention on Neurodegeneration (PT001)
JPND/0001/2022
Universidade de Coimbra; Universidade Nova de Lisboa ¿Laboratório de Instrumentação Engenharia Biomédica e Física da Radiação
Funders: Fundação para a Ciência e a Tecnologia
2021/01/01 - 2024/12/31
Overcoming the major roadblocks for successful AAV-based gene therapy in the CNS
2020.09668.BD
Universidade de Coimbra Instituto de Investigação Interdisciplinar
Funders: Fundação para a Ciência e a Tecnologia
2021/01/01 - 2025/10/31
Accelerating Research & Development for Advanced Therapies (ARDAT)
945473
PhD Student Fellow
Innovative Health Initiative
Funders: European Union; European Federation of Pharmaceutical Industries and Associations
2020/03
Laboratório de Análises Clínicas da Universidade de Coimbra - SARS-Cov2 Detection
LAC-UC
Other
Universidade de Coimbra
2020/06 - 2020/08
Validação expedita e Fabrico em larga escala de um dispositivo de sopro para colheita com inativação de amostras para deteção do SARS-CoV-2
269_596884125
Researcher
Universidade de Coimbra; Universidade de Coimbra Instituto de Investigação Interdisciplinar; ViraVector - Unidade de produção vectores virais para transferência de genes
Funders: Fundação para a Ciência e a Tecnologia; Agency for Clinical Research and Biomedical Innovation (AICIB)
2019/02/20 - 2019/09/30
Targeting ATXN3 for the treatment of Spinocerebellar Ataxia 3 (SCA3) using AAV5 and an artificial microRNA
NA
Researcher
Universidade de Coimbra Centro de Neurociências e Biologia Celular
Funders: uniQure NV
2019/12 - 2020/01
A Therapeutic Strategy in Machado-Joseph Disease
CPD0020A01
Researcher
Universidade de Coimbra Centro de Neurociências e Biologia Celular
Funders: Blade Therapeutics
2018/09 -
Targeting mutant ATXN3 for the treatment of Spinocerebellar Ataxia 3 (SCA3)
CSD3#IV0020
Researcher
Universidade de Coimbra Centro de Neurociências e Biologia Celular; Wave Life Sciences USA, Inc.
Funders: Wave Life Sciences USA, Inc.
2018/05/11 - 2020/12/31
BrainHealth 2020: Deteção Precoce, Neuro-modulação e Terapias Avançadas para Neuropatologias
SAICT 000008 BrainHealth 2020
Research Fellow
CNC.IBILI
5 10 out of 10 projects
We use cookies to improve your visit to our website.
